Buy Enaquadem Solution 20ml Online
Enaquadem Solution 20ml is marketed as a specialized injectable veterinary product for racing camels, with product information describing anti-inflammatory and diuretic properties. Available product listings also describe a proprietary formulation associated with corticosteroid-related and natriuretic peptide components.
Because the available information is primarily from commercial veterinary-supply listings rather than an official veterinary medicine database or manufacturer label, specifications and regulatory status should be verified before use or sale in any particular country.
What Is Enaquadem Solution 20ml?
Enaquadem Solution 20ml is presented commercially as an injectable formulation intended primarily for racing camels. Available descriptions associate the product with anti-inflammatory activity and a diuretic effect, and further describe its potential use in veterinary contexts involving inflammatory conditions.
Commercial product information states that the formulation contains a proprietary molecule described as being extracted from dexamethasone, together with ANP 28-17 and ANF 14-46 peptide sequences. However, because these details have not been verified against an official manufacturer dossier or regulatory product label, they should be treated as supplier-provided information rather than independently confirmed pharmaceutical specifications.
For veterinary professionals, the distinction is important: a commercial description does not by itself establish regulatory approval, therapeutic equivalence, competition eligibility, or authorization for a particular species or jurisdiction.
Enaquadem Solution Overview
| Product detail | Information available |
|---|---|
| Product | Enaquadem Solution |
| Presentation | 20ml vial |
| Marketed species | Racing camels |
| Product category | Injectable veterinary product |
| Commercially described purpose | Anti-inflammatory and diuretic support |
| Formulation | Proprietary/patented formulation according to supplier information |
| Reported formulation components | Dexamethasone-related extracted molecule, ANP 28-17 and ANF 14-46 peptide sequences |
| Storage information | Below 25°C, protected from direct sunlight; do not freeze |
| Professional oversight | Recommended |
The information above reflects currently available commercial product descriptions. It should not be interpreted as confirmation of regulatory authorization or a universally applicable veterinary indication.
Key Features of Enaquadem Solution 20ml
Injectable 20ml Presentation
Enaquadem Solution is commercially supplied in a 20ml vial, making the product a relatively small-volume presentation intended for professional veterinary applications.
Marketed for Racing Camels
Available listings specifically position Enaquadem Solution within the racing-camel market rather than presenting it as a general-purpose equine medicine.
Anti-Inflammatory Positioning
Commercial descriptions characterize the formulation as having anti-inflammatory activity and associate it with inflammatory conditions that may respond to corticosteroid-type treatment.
Reported Diuretic Effect
The product is also marketed as having a diuretic effect. This is an important pharmacological consideration and means that veterinary assessment is particularly relevant before use, especially where hydration, electrolyte balance, renal function, or cardiovascular status may be significant.
Proprietary Formulation
The available supplier description calls the formulation patented and identifies several molecular components. However, complete independently verified pharmaceutical specifications were not located in the available sources.
Ingredients and Formulation
According to the available commercial product description, Enaquadem Solution contains a proprietary formulation involving:
- A molecule described as being extracted from dexamethasone
- ANP 28-17
- ANF 14-46 peptide sequence
The supplier describes these as part of a patented formulation.
This information should be approached carefully because the available source does not provide a conventional official composition statement showing precise concentrations, excipients, manufacturing standards, or a validated regulatory monograph.
For professional purchasing, the safest approach is to confirm the current package label, manufacturer documentation, batch information, and regulatory status before relying on the formulation details.
Intended Veterinary Context
Enaquadem Solution is commercially promoted for racing camels, with descriptions focusing on inflammatory conditions and diuretic activity.
The available listing also mentions conditions described as:
- Rheumatic conditions
- Allergic conditions
- Dermatologic conditions
- Acute musculoskeletal inflammation
These descriptions come from commercial marketing material and should not be interpreted as a confirmed approved indication in every country.
A veterinarian should determine whether the product is appropriate for the individual animal, particularly when inflammatory disease could be associated with an underlying injury, infection, metabolic disorder, or systemic illness.
Potential Benefits and Considerations
Anti-Inflammatory Support
The primary commercial positioning of Enaquadem Solution relates to anti-inflammatory activity. Controlling inflammation can be an important component of veterinary management when inflammation has been properly diagnosed and the underlying cause has been evaluated.
Diuretic Activity
The reported diuretic effect distinguishes Enaquadem from a conventional anti-inflammatory product. Diuresis can influence fluid and electrolyte balance, so its use requires appropriate professional assessment.
Performance-Animal Context
Because Enaquadem Solution is marketed toward racing camels, competition considerations are particularly important. A product being commercially sold for racing animals does not automatically mean that its ingredients are permitted under the rules of a particular racing authority.
Owners, trainers, and veterinary professionals should check the applicable competition regulations before an animal participates in an event.
Product Presentation
Enaquadem Solution 20ml is reported to come as a 20ml vial.
Before purchasing, customers should verify:
- Exact vial size
- Manufacturer and country of origin
- Batch or lot information
- Expiry date
- Product labeling
- Packaging integrity
- Current formulation
- Applicable veterinary authorization
- Species and indication stated on the current label
This is especially important for products distributed internationally, where formulations, packaging, labeling, and legal status can differ between jurisdictions.
Storage and Handling
The available product information recommends storing Enaquadem Solution:
- Below 25°C
- Away from direct sunlight
- Protected from freezing
- With the container appropriately sealed
- Away from children
The supplier also states that the product should not be used if the seal has been broken.
Where the manufacturer’s current label provides different storage requirements, the manufacturer’s instructions should take precedence.
Safety and Veterinary Supervision
Enaquadem Solution should be treated as a professional veterinary product, particularly because the available information describes injectable administration and pharmacologically active anti-inflammatory and diuretic effects.
Veterinary supervision is important because inappropriate anti-inflammatory treatment can potentially mask clinical signs or delay diagnosis of an underlying condition. Diuretic activity may also have implications for hydration and electrolyte status.
The product should not be treated as a general-purpose performance enhancer or used simply because an animal is competing.
Important: This page intentionally does not provide an administration schedule or dosing instructions. Injectable veterinary products should be administered only according to verified product labeling and the direction of an appropriately qualified veterinarian.
Competition and Regulatory Considerations
For racing camels and other competition animals, medication rules can be strict.
The fact that a supplier markets Enaquadem Solution for racing does not establish that it is:
- Approved in every country
- Permitted by every racing authority
- Free from prohibited substances
- Appropriate for use immediately before competition
- Exempt from withdrawal or detection requirements
Competition regulations can change, and individual racing authorities may maintain their own prohibited-substance lists and medication policies.
Before treatment of a competition animal, the responsible veterinarian and trainer should verify the rules applicable to the specific event and jurisdiction.
Where To Buy Enaquadem Solution 20ml Online
When purchasing Enaquadem Solution 20ml, customers should prioritize reputable veterinary suppliers that provide transparent product information and appropriate documentation.
Before placing an order, confirm:
- The product is legally available in your jurisdiction.
- The supplied vial matches the advertised 20ml presentation.
- The packaging is sealed and intact.
- The batch and expiry information are available.
- The supplier can provide manufacturer or product documentation where appropriate.
- Import, veterinary-medicine, and prescription requirements are satisfied.
- The product is intended for the species and veterinary purpose for which it is being purchased.
International availability does not necessarily mean that a veterinary medicine is authorized for import or use in your country.
Frequently Asked Questions
What is Enaquadem Solution 20ml?
Enaquadem Solution 20ml is a commercially marketed injectable veterinary product primarily associated with racing camels. Supplier information describes anti-inflammatory and diuretic properties.
What size is Enaquadem Solution?
The available product description identifies Enaquadem Solution as a 20ml vial.
What animals is Enaquadem Solution marketed for?
The available commercial information specifically describes its use in racing camels.
What does Enaquadem Solution contain?
The supplier describes a proprietary formulation involving a molecule extracted from dexamethasone together with ANP 28-17 and ANF 14-46 peptide sequences. Complete independently verified concentrations were not found in the sources reviewed.
Is Enaquadem Solution an anti-inflammatory?
Commercial product information describes Enaquadem Solution as having anti-inflammatory activity and associates it with inflammatory conditions.
Does Enaquadem Solution have a diuretic effect?
Yes. Available commercial descriptions specifically market the product as having a diuretic effect in addition to its anti-inflammatory positioning.
How should Enaquadem Solution be stored?
The available product information recommends storage below 25°C, protection from direct sunlight, and avoiding freezing.
Can Enaquadem Solution be used in competition animals?
The product is marketed for racing camels, but commercial marketing should not be taken as confirmation that its use complies with a particular competition authority’s rules. Always check the current regulations governing the relevant event.
Is Enaquadem Solution suitable for horses?
The sources reviewed specifically describe Enaquadem Solution in connection with racing camels. They do not provide sufficient authoritative evidence to establish a general equine indication, so it should not be assumed to be approved or appropriate for horses.
Does Enaquadem Solution require veterinary supervision?
Because it is described as an injectable pharmacologically active veterinary product, professional veterinary oversight is strongly advisable. The appropriate use depends on the animal, diagnosis, product labeling, and applicable regulations.
Final Summary
Enaquadem Solution 20ml is a commercially marketed injectable product associated primarily with racing camels. Available supplier information describes anti-inflammatory and diuretic properties and reports a proprietary formulation involving a dexamethasone-derived molecule and specific peptide sequences.
Because independently verified regulatory and manufacturer documentation was not identified in the sources reviewed, customers should confirm the current label, manufacturer, formulation, legal status, and competition requirements before purchase or use.
For professional veterinary applications, product authenticity, correct storage, species suitability, and veterinary supervision should take priority over promotional claims.
WHAT IS Enaquadem Solution?
It has been 3 years in the research and development stage and we are finally able to release this breakthrough product to the Camel racing industry. Enaquadem Solution is used in racing Camels as an aid anti-inflammatory and well as having a diuretic affect as well. It also supports the management in various conditions including rheumatic, allergic and dermatologic which are known to be responsive to anti-inflammatory corticosteroids.
HOW DOES IT WORK?Enaquadem Solution
Enaquadem Solution is indicated for the treatment of acute musculoskeletal inflammation in Camels as well as a diuretic.
WHY USE?
It is a dual purpose anti-inflammatory which also has a diurectic effect, these actions are essential when it comes to racing Camels. There has been other variations of this medication in this area before, but due to the advancement in technologies and new testing procedures these medications cannot be used in a timely manner and have a withholding period. Enaquadem Solution can be used in full confidence and when used correctly within the treatment time frame you will be assured of great results. Enaquadem Solution is an essential for racing Camels and should be used in any training and racing program.
TREATMENT AND DOSAGE
Each 20ml has a potent dosage of a formulated anti-inflammatory as well as a diuretic. Administer 20ml IV 5 days before competition DO NOT treat Camel any closer than this withIt has been 3 years in the research and development stage and we are finally able to release this breakthrough product to the Camel racing industry.is used in racing Camels as an aid anti-inflammatory and well as having a diuretic affect as well. It also supports the management in various conditions including rheumatic, allergic and dermatologic which are known to be responsive to anti-inflammatory corticosteroids.

Reviews
There are no reviews yet.